FDA PMA FDA Class 3 Approved 🇺🇸 United States

Sensor, Glucose, Invasive

PMA: P120005 · Supplement: S028 · Decision Jan 23, 2015
Classifications
1
FEI Numbers
23
Registration Numbers
23

Basic Information

Device Name
Sensor, Glucose, Invasive
Trade Name
DEXCOM G4 PLATINUM CONTINUOUS MONITORING SYSTEM, DEXCOM SHARE SYSTEM
PMA Number
P120005
Supplement Number
S028
Device Class
FDA Class 3
Product Code
MDS
Generic Name
Sensor, glucose, invasive
Medical Specialty
Unknown
Advisory Committee
Clinical Chemistry
Decision
Approved
Decision Code
APPR
Decision Date
January 23, 2015
Date Received
September 12, 2014
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

FOR THE ADDITION OF A BLUETOOTH LOW ENERGY (BLE) RADIO TO BOTH THEADULT (MT20649) AND PEDIATRIC (MT22430) VERSIONS OF THE DEXCOM G4 PLATINUM RECEIVER,IDENTIFIED AS THE DEXCOM G4 PLATINUM RECEIVER WITH SHARE (ADULT - MT22495, PEDIATRIC -MT22608), AND FOR A MODIFICATION TO THE DEXCOM SHARE SYSTEM (STA-GL-400) ALLOWING THEDEXCOM G4 PLATINUM RECEIVER WITH SHARE TO COMMUNICATE DIRECTLY WITH THE DEXCOM SHARE2MOBILE APPLICATION INSTALLED ON A USER¿S APPLE MOBILE DEVICE. THE DEXCOM RECEIVER WITH SHAREIS A COMPONENT OF THE DEXCOM G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM, THEDEXCOM G4 PLATINUM PEDIATRIC CONTINUOUS GLUCOSE MONITORING SYSTEM, AND THE DEXCOMSHARE SYSTEM. THOUGH THE INDICATIONS FOR USE FOR THE DEXCOM G4 PLATINUM CONTINUOUSGLUCOSE MONITORING SYSTEM AND THE DEXCOM G4 PLATINUM PEDIATRIC CONTINUOUS GLUCOSEMONITORING SYSTEM ARE UNCHANGED BY THIS SUPPLEMENT, THE DEXCOM SHARE SYSTEM, AS MODIFIED,WILL BE MARKETED UNDER THE TRADE NAME DEXCOM SHARE SYSTEM AND IS INDICATED FOR:THE PURPOSE OF DEXCOM SHARE IS TO NOTIFY ANOTHER PERSON, THE FOLLOWER, OF THE PATIENT¿SDEXCOM G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM SENSOR GLUCOSEINFORMATION. DEXCOM SHARE PROVIDES SECONDARY NOTIFICATION AND DOES NOT REPLACE REAL TIMECONTINUOUS GLUCOSE MONITORING (G4 PLATINUM SYSTEM) OR STANDARD HOME BLOOD GLUCOSEMONITORING.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MDS Sensor, Glucose, Invasive